Genetic Risk Factor
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor (NCT06024408) | Regeneron Pharmaceuticals | 2024-05-21 |
Track Genetic Risk Factor automatically
Every clearance here is in the API, with alerts when new ones post.